David Ngo
*** ******* ***** ******, *** Jose, CA 95123
Cell: 415-***-**** E-mail: *********@***.*** Home: 408-***-****
Consistently Delivering Results
Three Consecutive Years of Exceeding Quota-HIV-Oncology (injectables)
QUALIFICATIONS
• Two plus years of experience in banking and finance sales
• Verifiable track record of generating million-dollar sales and of exceeding quota in Oncology, Virology, Respiratory, Allergy, Urology and Cardiology
• Highly experienced in oncology, virology, neurology, psychiatry, respiratory, allergy, dermatology, urology, endocrinology and cardiology; calling on Stanford and UCSF
• Cultivated relationships with key directors of pharmacy, pharmacy buyers, nurses to gain instant access
• Launched Zagam, Agenerase, Trizivir, Advair, Reyataz and Sprycel
PROFESSIONAL EXPERIENCE
10/13/08 to 07/31/09 Upstate Pharma, Professional Sales Representative
Temporary Contract sales to psychiatrists in the Oakland, Berkeley, Walnut Creek, Antioch, Modesto, Stockton, San Ramon, Pleasanton, Fremont, San Francisco, Peninsula, Palo Alto and San Jose, Los Gatos, Santa Cruz and Monterey, selling a branded generic of Effexor XR, an antidepressant
Achievement: documented record of putting a branded generic of anti-depressant, Venlafaxine ER Tablets on the Health Plan of San Mateo formulary
05/27/08 to 10/12/08, EdwardJones Investment, Licensed Financial Advisor:
sold retirement plans, stocks and bonds, tax saving investments
02/06/06 to 01/24/08, Bristol-Myers Squibb, Oncology Division, Senior Sales Representative
Responsibilities: promoted INJECTIABLES in biologics, EGFR inhibitor, Erbitux, for metastatic colon and head, and neck cancers and tyrosine kinase inhibitors, Sprycel, for chronic myeloid leukemia; called on pharmacists, nurses, oncologists, hematologists, radiation oncologists at retail and at UC San Francisco and Stanford, from San Francisco, Palo Alto, San Jose to Monterey
Achievements: 1st Quarter 2006, 117% of goal
2nd Quarter 2006, 126%
3rd Quarter 2006, 137%
4th Quarter 2006 144%
Grew Erbitux sales by 66% from $4 million to $6.5 million
1st Quarter to 3rd Quarter 96% 2007
Ranked 22 out of 61 in the Nation
No 1 in the Nation in Sprycel and Erbitux Weekly sales 2007
Grew Sprcel sales from $92,000 to $1 million in 2007
05/07/03 to 02/06/06, Bristol-Myers Squibb, Virology Division, Senior Sales Representative
Responsibilities: Called on HIV treaters at Stanford, UCSF, promoted Reyataz, Sustiva, Zerit and Videx EC
Achievements: Generated $4 million in HIV product sales, Sustiva and Reyataz
• Launched Reyataz June 2003, Part of No. 1 District in Reyataz sales
• 2003: 3rd Quarter, 164% of goal
4th Quarter, 135% of goal
• 2004: 1st Quarter, 136%
2nd Quarter, 143%
3rd Quarter, 227%
4th Quarter, 141%
• 2005: 1st Quarter, 139% of goal, No. 1 in the District
2nd Quarter, 160% of goal, No. 1 in the District
3rd Quarter, 137% of goal
4th Quarter, 175% of goal
• Compliments from VP of Marketing, “WOW!”, from Director of Sustiva Marketing, “Your knowledge of the science and data were outstanding…” from a key customer, “Do you have a PhD?”
08/01 to 04003, Novartis Pharmaceuticals, Neuroscience Specialty Division, Neuroscience Associate
Responsibilities: Teamed with Specialty/Primary Care counter parts /Managed Care/Medical Scientist/Management/Marketing to promote Exelon, Trileptal and Comtan for Alzheimer’s Disease, Epilepsy and Parkinson’s Disease
Achievements:
• Doubled the market share of Trileptal (epilepsy treatment) within a year
• Helped change promotional messages of Trileptal resulting in $100 million increased sales for Marketing
• Acted as a resource person for the district and the region by providing the latest published data and competitive information available from Medline
01/01 to 07/01, GlaxoSmithKline, Respiratory Division, Management Trainee/Therapeutic Area Specialist
Responsibilities: Trained and mentored field representatives on skills needed to call on specialists, thought leaders and residents; coordinated with team sales objectives and coverage of hospital- and retail-based specialists, high prescribing physicians and thought leaders; maintained a high level of scientific expertise and served as a resource on product and disease state knowledge
Achievements:
• No. 3 in the Region at 105% of goal
• Launched Advair April 2001, $3-billion dollar plus asthma/COPD inhaler
• Led a dinner program for the entire Western Region
05/99 to 12/00, GlaxoWellcome, HIV Division, Senior Sales Representative
Responsibilities: managed a $10-million territory in promoting nucleoside reverse transcriptase inhibitor (NRTI)--Combivir, Ziagen, Trizivir and protease inhibitor (PI)--Agenerase to Infectious Disease specialists at Stanford University and at UC San Francisco emphasizing on genotypic and phenotypic resistance testing; Medline search to stay informed about the latest studies and competitive activity; built on skill set through ongoing continuous training
Achievements: Generated $1.1 million sales in HIV products, Combivir-Ziagen-Agenerase
• Top representative in the Region on market-share-take-away of competitive product (Combivir vs. Zerit), January to May 2000
• Peak Performer Winners in 1999 and 2000 at 106% of goal
• Launched Agenerase May 1999, Trizivir June 2000
• Viewed by customers as a valuable information resource
06/97 to 05/99, GlaxoWellcome, Respiratory Division, Senior Sales Representative
Responsibilities: promoted inhaled, topical steroids and long-acting beta2 agonist (Flovent, Flonase and Serevent) to Internists, Family Practitioners, Allergists and Pulmonologists in a highly managed-care environment in San Francisco
Achievements:
• Peak Performer Winner 1998 at 103%
• No. 2 in the Region 1998
10/96 to 06/97, Rhone-Poulenc Rorer, Professional Sales Representative
Responsibilities: promoted respiratory products (Azmacort, Nasacort AQ, Intal and Tilade) in Redwood City, Palo Alto, Mountain View and Sunnyvale
Achievements:
• Launched Zagam February 1996, antibiotic
• Put Nasacort AQ on El Camino formulary in two months by developing rapport with the Director of P & T and a key influential allergist
06/92 to 10/96, Roberts Pharmaceutical, Professional Sales Representative
Responsibilities: promoted burn dressing Furacin to dermatologists, Noroxin to urologists, Tigan to oncologists, anti-hypertensive to internists, Nitrodisc to cardiologists, Furoxone and Nucofed to pediatricians, Eltroxin to endocrinologists
Achievements:
• Top sales representative on Noroxin in the Region averaged at 110% six months in a roll
• Helped management in getting State Medi-Cal to cover Noroxin and helped Marketing Department in its promotional message
EDUCATION: San Francisco State University, Bachelor of Science in Finance, 1989
OTHER TRAINING: Evidence-Based Medicine, Seminar, April 2001
Public Speaking, Dale Carnegie graduate, April 2000
High Impact Presentation, Dale Carnegie graduate, January 2007